Pembroke House, 28 - 32, Pembroke Street Upper Dublin 2 Dublin, D02 EK84 IrelandCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

Nove Butovice, building C, 4th floor, Bucharova 2657/12, Prague, 158 00, Czech RepublicCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

Office 407, 4th floor, 11, Giorgi Saakadze descent Tbilisi, 0160 GeorgiaCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

3rd floor, Rákóczi street, 42 (EMKE Building), 1072 Budapest, HungaryCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

Office 11, floor 3, build. 619, Prospekt Mira, 119, Moscow, 129223, RussiaCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

35/58, Kyrovogradskaya str. Kyiv, 03069 UkraineCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

29 ulitsa Marshala Koneva, Smolensk, Smolenskaya oblast' 214019, RUCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

2 Pembroke Road Dublin, County Dublin IrelandCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.

3042 Northwest Monte Vista Terrace, Portland, OR 97210, USCromos™ Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical monitoring & outsourcing to Geоrgia, Belarus, Russia, Ukraine, Baltic States‎, countries of Eastern Europe and Israel. The company has been successfully managing Phase I-IV clinical trials, bioequivalence and observational studies since 2004. Our business model is a product of the most validated Western solutions which are carefully tailored to local environments. Cromos™ Pharma has a proven track record of rapid patient accrual and retention that often exceeds other geographies by a factor of 5. As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team". In 2012 Cromos™ Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead. Cromos™ Pharma’s industry-leading proprietary CTMS further increases company’s internal efficiency and performance and empowers sponsors by providing them with real-time access to operational, administrative and financial information about their studies. Cromos™ Pharma's risk-sharing clinical development platform allows the sponsors to pay for performance and is our guarantee that the study timelines will be met. It also offers biotech, pharma and device companies with promising technologies several unique business partnership algorithms, including clinical research program conduct in exchange for equity or licensing opportunities. We invite interested pharmaceutical, biotech, and medical device companies to reach out to us for an in depth evaluation of potential strategic partnerships.